Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Current Deferred Revenue: 2019-2025

Historic Current Deferred Revenue for SRx Health Solutions (SRXH) over the last 6 years, with Q2 2025 value amounting to $38000.0.

  • SRx Health Solutions' Current Deferred Revenue changed N/A to $38000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $38000.0, marking a year-over-year change of. This contributed to the annual value of $500000.0 for FY2024, which is 704285.71% up from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Current Deferred Revenue is $38000.0.
  • SRx Health Solutions' Current Deferred Revenue's 5-year high stood at $500000.0 during Q4 2024, with a 5-year trough of $7000.0 in Q4 2023.
  • Over the past 4 years, SRx Health Solutions' median Current Deferred Revenue value was $169000.0 (recorded in 2021), while the average stood at $229000.0.
  • In the last 5 years, SRx Health Solutions' Current Deferred Revenue tumbled by 909.09% in 2021 and then skyrocketed by 704285.71% in 2024.
  • Quarter analysis of 4 years shows SRx Health Solutions' Current Deferred Revenue stood at $300000.0 in 2021, then crashed by 97.67% to $7000.0 in 2023, then surged by 7042.86% to $500000.0 in 2024, then tumbled by 92.4% to $38000.0 in 2025.
  • Its Current Deferred Revenue was $38000.0 in Q2 2025, compared to $500000.0 in Q1 2025 and $500000.0 in Q4 2024.